Literature DB >> 16645170

Definitive-like erythroid cells derived from human embryonic stem cells coexpress high levels of embryonic and fetal globins with little or no adult globin.

Kai-Hsin Chang1, Angelique M Nelson, Hua Cao, Linlin Wang, Betty Nakamoto, Carol B Ware, Thalia Papayannopoulou.   

Abstract

Human embryonic stem cells are a promising tool to study events associated with the earliest ontogenetic stages of hematopoiesis. We describe the generation of erythroid cells from hES (H1) by subsequent processing of cells present at early and late stages of embryoid body (EB) differentiation. Kinetics of hematopoietic marker emergence suggest that CD45+ hematopoiesis peaks at late D14EB differentiation stages, although low-level CD45- erythroid differentiation can be seen before that stage. By morphologic criteria, hES-derived erythroid cells were of definitive type, but these cells both at mRNA and protein levels coexpressed high levels of embryonic (epsilon) and fetal (gamma) globins, with little or no adult globin (beta). This globin expression pattern was not altered by the presence or absence of fetal bovine serum, vascular endothelial growth factor, Flt3-L, or coculture with OP-9 during erythroid differentiation and was not culture time dependent. The coexpression of both embryonic and fetal globins by definitive-type erythroid cells does not faithfully mimic either yolk sac embryonic or their fetal liver counterparts. Nevertheless, the high frequency of erythroid cells coexpressing embryonic and fetal globin generated from embryonic stem cells can serve as an invaluable tool to further explore molecular mechanisms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16645170      PMCID: PMC1895504          DOI: 10.1182/blood-2005-11-011874

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

1.  "Maturational" globin switching in primary primitive erythroid cells.

Authors:  Paul D Kingsley; Jeffrey Malik; Rachel L Emerson; Timothy P Bushnell; Kathleen E McGrath; Laura A Bloedorn; Michael Bulger; James Palis
Journal:  Blood       Date:  2005-11-01       Impact factor: 22.113

2.  Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment.

Authors:  Jörgen Adolfsson; Robert Månsson; Natalija Buza-Vidas; Anne Hultquist; Karina Liuba; Christina T Jensen; David Bryder; Liping Yang; Ole-Johan Borge; Lina A M Thoren; Kristina Anderson; Ewa Sitnicka; Yutaka Sasaki; Mikael Sigvardsson; Sten Eirik W Jacobsen
Journal:  Cell       Date:  2005-04-22       Impact factor: 41.582

3.  Forced aggregation of defined numbers of human embryonic stem cells into embryoid bodies fosters robust, reproducible hematopoietic differentiation.

Authors:  Elizabeth S Ng; Richard P Davis; Lisa Azzola; Edouard G Stanley; Andrew G Elefanty
Journal:  Blood       Date:  2005-05-24       Impact factor: 22.113

4.  Differentiation of human embryonic stem cells into hematopoietic cells by coculture with human fetal liver cells recapitulates the globin switch that occurs early in development.

Authors:  Caihong Qiu; Eric Hanson; Emmanuel Olivier; Mari Inada; Dan S Kaufman; Sanjeev Gupta; Eric E Bouhassira
Journal:  Exp Hematol       Date:  2005-12       Impact factor: 3.084

5.  Three pathways to mature macrophages in the early mouse yolk sac.

Authors:  Julien Y Bertrand; Abdelali Jalil; Michèle Klaine; Steffen Jung; Ana Cumano; Isabelle Godin
Journal:  Blood       Date:  2005-07-14       Impact factor: 22.113

6.  Controlled-rate freezing of human ES cells.

Authors:  Carol B Ware; Angelique M Nelson; C Anthony Blau
Journal:  Biotechniques       Date:  2005-06       Impact factor: 1.993

7.  Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development.

Authors:  Elias T Zambidis; Bruno Peault; Tea Soon Park; Fred Bunz; Curt I Civin
Journal:  Blood       Date:  2005-04-14       Impact factor: 22.113

8.  Hematopoietic colony-forming cells derived from human embryonic stem cells.

Authors:  D S Kaufman; E T Hanson; R L Lewis; R Auerbach; J A Thomson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-04       Impact factor: 11.205

9.  VEGF-A165 augments erythropoietic development from human embryonic stem cells.

Authors:  Chantal Cerdan; Anne Rouleau; Mickie Bhatia
Journal:  Blood       Date:  2003-12-04       Impact factor: 22.113

10.  Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential.

Authors:  Maxim A Vodyanik; Jack A Bork; James A Thomson; Igor I Slukvin
Journal:  Blood       Date:  2004-09-16       Impact factor: 22.113

View more
  55 in total

1.  Reprogramming based gene therapy for inherited red blood cell disorders.

Authors:  Xiuling Xu; Jing Qu; Keiichiro Suzuki; Mo Li; Weizhou Zhang; Guang-Hui Liu; Juan Carlos Izpisua Belmonte
Journal:  Cell Res       Date:  2012-04-03       Impact factor: 25.617

Review 2.  A case of cellular alchemy: lineage reprogramming and its potential in regenerative medicine.

Authors:  Grace E Asuelime; Yanhong Shi
Journal:  J Mol Cell Biol       Date:  2012-02-27       Impact factor: 6.216

Review 3.  The potential of stem cells as an in vitro source of red blood cells for transfusion.

Authors:  Anna Rita Migliaccio; Carolyn Whitsett; Thalia Papayannopoulou; Michel Sadelain
Journal:  Cell Stem Cell       Date:  2012-02-03       Impact factor: 24.633

4.  Transcriptional environment and chromatin architecture interplay dictates globin expression patterns of heterospecific hybrids derived from undifferentiated human embryonic stem cells or from their erythroid progeny.

Authors:  Kai-Hsin Chang; Andy Huang; Hemei Han; Yi Jiang; Xiangdong Fang; Chao-Zhong Song; Steve Padilla; Hao Wang; Hongzhu Qu; John Stamatoyannopoulos; Qiliang Li; Thalia Papayannopoulou
Journal:  Exp Hematol       Date:  2013-08-28       Impact factor: 3.084

5.  Surface antigen phenotypes of hematopoietic stem cells from embryos and murine embryonic stem cells.

Authors:  Shannon L McKinney-Freeman; Olaia Naveiras; Frank Yates; Sabine Loewer; Marsha Philitas; Matthew Curran; Peter J Park; George Q Daley
Journal:  Blood       Date:  2009-05-06       Impact factor: 22.113

6.  Differences in lymphocyte developmental potential between human embryonic stem cell and umbilical cord blood-derived hematopoietic progenitor cells.

Authors:  Colin H Martin; Petter S Woll; Zhenya Ni; Juan Carlos Zúñiga-Pflücker; Dan S Kaufman
Journal:  Blood       Date:  2008-07-11       Impact factor: 22.113

Review 7.  Induced pluripotent stem cell (iPSCs) and their application in immunotherapy.

Authors:  Zhengping Jiang; Yanmei Han; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2013-12-16       Impact factor: 11.530

8.  Generation of functional erythrocytes from human embryonic stem cell-derived definitive hematopoiesis.

Authors:  Feng Ma; Yasuhiro Ebihara; Katsutsugu Umeda; Hiromi Sakai; Sachiyo Hanada; Hong Zhang; Yuji Zaike; Eishun Tsuchida; Tatsutoshi Nakahata; Hiromitsu Nakauchi; Kohichiro Tsuji
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-28       Impact factor: 11.205

9.  Human adipose tissue contains erythroid progenitors expressing fetal hemoglobin.

Authors:  Amparo Navarro; Francisco Carbonell-Uberos; Severiano Marín; María Dolores Miñana
Journal:  World J Stem Cells       Date:  2013-10-26       Impact factor: 5.326

Review 10.  De novo generation of HSCs from somatic and pluripotent stem cell sources.

Authors:  Linda T Vo; George Q Daley
Journal:  Blood       Date:  2015-03-11       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.